Tuberculosis
Vaccine
Research at the Interface Between
Christian Lienhardt, Stop TB
Partnership
The Role
of Fundamental Research in Global TB Control
Session 2 - Applied Research
Hazel Dockrell,
The
Challenge of
Correlates of Immunity
Carlos Martin, Universidad de Zarazoga
Development of a New Attenuated Vaccine: From Preclinical to Clinical Evaluation
Tom Ottenhoff, Leiden University Medical Center
Current Breakthroughs in Immunology
David Lewinsohn, Oregon Health & Science University
Current Breakthroughs in ImmunologySession 3 - Manufacturing, Regulation, & Vaccine Access
Lewellys F. Barker, Aeras Global TB Vaccine Foundation
Economic Issues in TB Vaccine Development
Daniel Chin, The Bill & Melinda Gates Foundation
Vaccine Access To China: Opportunities & Challenges
Camille Locht, Inserm/Institut Pasteur de Lille
Thursday
Session 4 - Clinical Studies on TB Vaccines
Hassan Mahomed, South African Tuberculosis Vaccine Initiative
Clinical Research Issues in TB Vaccine Development
Thomas G. Evans, Aeras Global TB Vaccine Foundation
Helen McShane, Oxford University
Jerald Sadoff, Crucell
Søren Hoff, Statens Serum Institut
Leander Grode, Vakzine Projekt Management